Pot Stock Alert: This Company Has the Biggest Upside in 2020

Cannabis stocks have been in a world of pain this year. Nearly every pot stock has been hit hard, with some losing as much as 90% of their value. Once a billion-dollar company, Green Organic Dutchman Holdings (TSX:TGOD) is now valued at just $250 million. In 2020, however, sales could surge to historic levels. And judging by recent data, the cannabis…

Read More

Why Did Canopy Growth (TSX:WEED) Stock Gain Almost 20% Yesterday?

Shares of Canada’s top cannabis company, Canopy Growth (TSX:WEED)(NYSE:CGC) rose close to 20% on November 20, 2019. The stock lost 33% in market value between November 8 and November 18, as the company reported underwhelming September-quarter results. Canopy disappointed investors with less-than-estimated revenue and earnings. Poor earnings of several other cannabis companies resulted in mayhem in the last week. Canopy…

Read More

This Cannabis Stock Gained Amid Massive Market Decline Yesterday

The underwhelming earnings of top cannabis players have resulted in a bloodbath. Aurora Cannabis, Canopy Growth, and Cronos stock have fallen considerably in the last two trading days. ACB is down 36%, Canopy Growth is down 30%, and Cronos Group has slumped 27% since Friday. While these cannabis giants continued to lose market value, there was one company that was…

Read More

Why Aurora (TSX:ACB) Stock Is Worse for Trading Than Canopy Growth (TSX:WEED) Stock

For some reason, investors are more interested in Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock than in Canopy Growth (TSX:WEED)(NYSE:CGC) stock. However, I believe the latter is a better stock to invest in. Being in the cannabis industry and losing money, both companies are speculative investments. It doesn’t matter if the businesses experience extraordinary revenue growth when they’re posting net losses. As a…

Read More

TFSA Investors: 3 Must-Avoid Mistakes Holding Back Your Performance

Investing is not easy, and for most investors it will seem pretty difficult. Even professional money managers have their struggles in the market. The key is, every time something bad happens, the investor should take away at least one lesson. Building on each of these lessons you learn and lessons from others will help you to avoid making the same…

Read More

Contrarian Investors: Is Aurora Cannabis (TSX:ACB) Stock a Buy?

With equity markets trading near all-time highs, contrarian investors are searching for troubled stocks that have fallen out of favour and might offer a shot at some big gains on a turnaround. Let’s take a look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) to see if it deserves to be on your buy list today. Tough run Aurora Cannabis trades at $6.50 per…

Read More

Go Long on “Big Cannabis” and Ignore Edibles?

Unless you’re a momentum trader looking for some quick upside, the legalization of edibles next month should be given a wide berth by long-term investors. Instead, a low-risk, long-range position in a big player such as Canopy Growth (TSX:WEED)(NYSE:CGC) may seem the wisest option for newcomers looking to gain upside from the cannabis industry. The rebooted cannabis space may be…

Read More

Why Curaleaf Holdings (CNSX:CURA) Rose 10% in the Last Week

Shares of leading cannabis company Curaleaf Holdings (CNSX:CURA) have risen 10% in the last week of August 2019. The stock is currently trading at $9.41. Despite the recent rally, Curaleaf shares are still trading 40% below their 52-week high. Stock rose despite missing revenue and earnings estimate Curaleaf is a Canada-based vertically integrated cannabis company in the U.S. Curaleaf announced…

Read More

Why This Cannabis Stock Might Be the Best 1 to Invest in Today

Cannabis investors have no shortage of options when it comes to potential pot stocks to invest in. Unfortunately, there are many more bad ones out there than there are good ones. From burning lots of cash to trading at very high multiples and not being anywhere near recording a profit, there are many reasons why value-oriented investors would want to…

Read More

3 Reasons Cronos Group’s (TSX:CRON) Q2 Results Aren’t Enough to Make the Stock a Buy

Cronos Group (TSX:CRON)(NASDAQ:CRON) has undoubtedly been one of the most expensive marijuana stocks in the entire industry. Despite not having the sales volumes that some of the bigger players in the industry have, with a market cap of more than $5 billion, investors have been more than willing to buy the stock at its very high valuation. Last week, the…

Read More